AzTrials
AzTrials

StrokeMITTXSNCT06213376

MIT Intensive Treatment Study

A study testing Melodic Intonation Therapy and Video Feedback Performance Review in people with Stroke and Aphasia, run by Nevada State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Aphasia, Motor Speech
What is being tested?
Melodic Intonation Therapy and Video Feedback Performance Review
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1 participants
Where
1 siteUnited States
Study dates
28 Dec 2023to 23 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Fluent English speakers
  • Sustained a left-hemisphere stroke
  • Presents with language and motor speech impairments

Who cannot join

  • • History of learning disability prior to accident (per patient report)
  • Uncorrected auditory or visual impairments
  • Not meeting the criteria of stroke
  • Failure to provide evidence of stroke diagnosis (medical record history)
  • History of psychiatric disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Nevada State University

    Henderson, Nevada, 89002

Other trials in United States

About this study

Official title: Intensive MIT Paired With Video Feedback for Motor Speech Disorders and Aphasia

This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval.

Being tested
Melodic Intonation Therapy, Video Feedback Performance Review
Medical subject headings
Stroke, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Melodic Intonation TherapyBehavioural

    Melodic Intonation Therapy uses intonation and melody to aid individuals with aphasia with producing words.

  • Video Feedback Performance ReviewBehavioural

    Participant will view recording to judge correct and incorrect productions of trained words and to identify motor techniques increasing intelligibility

Study groups in NCT06213376
Study groupRoleWhat they receive
InterventionExperimental20 sessions/4 weeks: Video Feedback: S1) Participant (P1) views recording of previous session with the clinician \& judges whether the production is intelligible. S2) S1 \& the clinician identifies changes in motor movements that are influencing performance. S3+S4) S1+S2 \& given support from the clinician, P1 identifies techniques improving intelligibility \& modifies behavior accordingly. MIT (Albert et al., 1973; Helm-Estabrooks et al., 2014): Humming - Clinician introduces the target phrase by showing a visual cue, humming the phrase, then intoning the phrase while P1 taps left-hand. Simultaneous production with melody - The Clinician and P1 melodically produce the target phrase \& tap together. Simultaneous melodic production accompanied by gradual reduction of clinician support. Immediate repetition response to probe question - Following P1's successful repetition, the clinician melodically produces a question and P1 melodically produces the target.
Receives: Behavioral: Melodic Intonation Therapy; Behavioral: Video Feedback Performance Review

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intelligibility

    Intelligibility as measured by percentage of consonants correct and by targets produced on trained and untrained stimuli. 20 trained and 20 untrained speech phrases that are relevant to the client (measured during reading and repetition tasks)

    Measured: From enrollment to 4 weeks post treatment

Secondary outcomes (4)
  1. Apraxia Battery for Adults

    A test to measure the presence and severity of apraxia in adults

    Measured: Baseline and one week following the end of treatment

  2. Assessment of Intelligibility of Dysarthria Speech

    A tool for quantifying single-word intelligibility, sentence intelligibility, and speaking rate of adult speakers with dysarthria

    Measured: Baseline and one week following the end of treatment

  3. Longer Connected Speech Assessment

    Change in Performance on Rainbow Passage- A public domain paragraph frequently used by speech-language pathologists to gather a speech sample of all phonemes for American English

    Measured: Baseline and one and four weeks following the end of treatment

  4. Quality of Life with Dysarthria (QOLdys)

    A reliable and valid tool to assess quality of life for patients with dysarthria.

    Measured: Baseline and four weeks following treatments.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jan 2024
  2. Study start28 Dec 2023
  3. Primary completion23 Feb 2024
  4. Study completion23 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Single-subject experimental design
Masking
None (open label)
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06213376
Sponsor's protocol ID
2312-0370
Acronym
MITTXS
Status last verified
Aug 2024
First submitted
9 Jan 2024
Last updated
30 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Albert ML, Sparks RW, Helm NA. Melodic intonation therapy for aphasia. Arch Neurol. 1973 Aug;29(2):130-1. doi: 10.1001/archneur.1973.00490260074018. No abstract available.

    PubMed 4717723
  • Helm-Estabrooks, N., Albert, M. L., & Nicholas, M. (2014). Manual of aphasia and aphasia therapy (3rd ed.). Austin, TX: Pro-Ed

  • Zumbansen A, Peretz I, Hebert S. Melodic intonation therapy: back to basics for future research. Front Neurol. 2014 Jan 28;5:7. doi: 10.3389/fneur.2014.00007. eCollection 2014.

    PubMed 24478754

Questions about this trial

What is this clinical trial studying?

A study testing Melodic Intonation Therapy and Video Feedback Performance Review in people with Stroke and Aphasia, run by Nevada State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intelligibility (time frame: From enrollment to 4 weeks post treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06213376, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
MIT Intensive Treatment Study (NCT06213376) | AzTrials